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Elevation of plasma facto; VIII procoagulant activity can be seen in many hypercoagulable states including stress, acute phase reaction and chronic intravascular coagulation (IVC) .
In this study procoagulant factor VIII was measured by both the PTT-VIII assay and the thromboplas tin generation time assay (TGT-VIII) and compared to an immunologic assay for VIII antigen. An in vitro study of thrombin and thromboplastin treated normal plasma shared PTT-VIII values of 168-568% of normal, TGT-VIII, 60-125%, and VIII-antigen, 84-100%. Similar in vivo findings were noted in patients with laboratory and clinical evidence of chronic IVC: Sickle cell crisis  600  300  290  Sickle cell crisis  376   150  190  Venae cava thrombosis  336  140  200  Metastatic neuroblastoma 240  135  145  Ulcerative colitis  300  150  60 Another group (pregnancy, post-exercise, untreated tumor patients) showed elevated VIII levels which were the same by all three assays.
In conclusion, in hypercoagulability associated with IVC, measurements of factor VIII are like that seen in thrombin treated plasma (activated VIII) while in hypercoagulability seen with acute phase reaction the elevation of factor VIII is not related to activation. The association of amino aciduria and cancer has been previously observed, however systematic study of excretion in specific tumors has not been investigated. The mean values of 17 amino acids excreted in 24 hour specimens were established in 28 healthy children. The mean values of the following amino acids expressed as mg/substance/gram creatinine were significantly elevated, i.e. a 4 fold increase or more, when compared with control values ( ) in 28 children with disseminated neuroblastoma: hydroxyproline 31.0 (1.0), glutamic acid 26.8 (4.6), aspartic acid 16.2 (3.9), citrulline 3.4 (0.2), allodelta-hydroxylysine 11.2 (1.8), ornithine 5.2 (1.2), 3-methylhistidine 104.0 (24.4). Normal or less than 4 fold increases in mean excretion values for proline (3.7), glutamine (62.4), ethanolamine (11.1), phosphoethanolamine (10.2), methionine sulfoxide (18.1), asparagine (26.7), glucosamine (0.7), carnosine (9.1), arginine (1.9), 1-methylhistidine (15.3) were found. Values from 12 other children with successfully treated neuroblastoma were similar to controls. Seven children with hepatic cancer had significantly increased excretion of all amino acids studied except phosphoethanolamine, methionine sulfoxide and asparagine. The source of the increased excretion appears to be extra renal in children with neuroblastoma and may in addition be due to abnormal liver function in children with hepatic cancer. Supported by NCI Grant No. CA 05826.
ocnusIvE CRISES IN SICKLE CELL ANEMIA Jilly, P.N., Uy, C.G., Hudson, R.L., Scott, R.B., and Bullock, W.H. Center for Sickle Cell Disease, Howard University College of Medicine, Washington, D.C.
The safety and efficacy of the use of urea for the clinical remission of painful crisis in Sickle Cell Anemia has been the subject of extensive investigations and controversy.
Twenty-eight crises, 7 occurring in children and 21 in adults, all homozygous for hemoglobin S,were evaluated in a double blind study to determine the clinical responses observed following administration of either 15% urea in 10% invert sugar (14 crises) or 10% invert sugar (14 crises.) There was no statistically significant difference in the duration of pain in those receiving urea in invert sugar compared with those receiving invert sugar alone. Among those receiving urea, there was no significant difference in the peak BUN level or the time at which the peak level was reached in those responding compared with those who obtained no response. The fluid balance in the urea treated group was variable and a trend towards negative fluid balance was noted in both the success and failure groups. Patients who were receiving invert sugar alone were generally kept in positive fluid balance.
The response to therapy was observed to be unrelated to (1) the severity and duration of pain or (2) to other modes of therapy received prior to the study and (3) to treatment with urea or invert sugar alone.
INDIUM-BLEOMYCIN SCANNING IN PEDIATRIC MALIGNANT SOLID TUMORS.
Helen Johnson, James J. Corrigan, Jr., Robert E. O'Mara, David Lilien. Department of Pediatrics and Radiology, University of Arizona Medical Center, Tucson, Arizona.
'lllndium labelled Bleomycin (IB) is a new radio-pharmaceutical which localizes in a wide variety of animal and human tumors. In this study of 13 children with malignant solid tumors 20 total body scans were performed. The scans were obtained 48 hours after intravenous administration of less than 2 millicuries of IB (Bleomycin less than 0.4 mg/ dose). In 3 patients with lymphoma, 5 with neuroblastoma, 2 with rhabdomyosarcoma, 1 with leiomyosarcoma, and 2 with malignant teratoma an excellent correlation was observed between abnormal accumulations of IB and known sites of tumor involvement. The most precise imaging of tumor was for lymph node and soft tissue sites of disease, both above and below. the diaphragm. At 48 hours IB was normally observed in liver, kidneys, and bone marrow. Hepatic and osseous involvement was difficult to assess, necessitating other specific scanslfpr evaluation. The data suggest that tumor scanning with Indium-Bleomycin is an extremely valuable technique for staging and serial evaluation of children with solid tumors. has not been well documented. We now report that, in a manner These tumors are generally resistant to chemtherapy. During similar to binding of sheep erythrocytes, under appropriate the past 2 1/2 years 14 patients with metastatic C6 and 2 with temperature conditions, human T cells bind human autologous metastatic HE were treated with incremental HDM (50 to 800 mq/ and homologous erythrocytes. When human lymphocytes or thymokg) over 6 hours at 2 to 3 weekly' intervals followed by CF 2 cytes were incubated with human red cells in ice for 30-90 hours later. Among 14 patients with C6, complete regression min,, resuspended, and examined at 4 O , the percentages of roof pulmnary metastases occurred in 2 and partial regression settes formed were as follows: adult peripheral blood lymphoin 2 others (duration of response 2-30+ months). Treatment cytes 952%; cord blood lymphocytes 9fr6%; malignant T-lymphowas given for 2 years or until tumor recurred. One of 3 blast cell lines 5%; thymocytes 22+10%. Only viable lymphopatients who relapsed on the 6-hour infusion responded again cytes formed rosettes, Binding of human erythrocytes did not to 24-hour infusions. One patient with HE partially responded occur after lymphocyte suspensions were depleted of T cells, (duration 2 months) while the other remains free of disease &t nor after treatment with non-cytotoxic concentrations of antimonths following initiation of HDM and eradication of metastathymocyte serum, trypsin or sodium azide. At 22", or when ses with radiotherapy. Of 150 courses of methotrexate, 20% vigorously agitated, rosettes rapidly fell apart. Similar were associated with side effects: nausea, vomiting, abdominal numbers of rosettes formed with either autologous or homolopain, stomatitis, skin lesions, renal impairment and myelosupgous human erythrocytes, pression. Side effects responded to additional CF. HDM with
HIal E W E METHOTREXATE (HDM) WITH CITIIOVORUM (CF) RESCUE IN HUMAN T CELLS BIND AUTOLOGOUS AND HOMOLOGO~S HUMAN RED CELLS. nlE MANAGEMENT OF BONE
The binding of autologous and homologous, as well as heter-CF is ncw being used as adjuvant treatment in newly diagnosed ologous erythrocytes, in addition to being a convenient T patients. Of 12 such patients followed for 2-18 months, only cell marker, supports the concept that T cells have a general 1 has developed a metastasis, a striking reduction in inciaffinity for surface components of other cells. dence. HDM appears to be of great value in bone tumor therapy i n childhood. Supported by USPHS grant C6516.
